Filter
52
Filtered Results: 52
Text search:
R.
Barnabas
Featured
Recommendations
7
New Publications
3
Language
Document type
Guidelines
26
Studies & Reports
13
No document type
10
Manuals
3
Countries / Regions
Burkina Faso
2
Malawi
2
Global
2
South Africa
2
Kenya
1
Lesotho
1
Mozambique
1
Africa
1
Latin America and the Carribbean
1
Tanzania
1
Brazil
1
Russia
1
Namibia
1
Ethiopia
1
Angola
1
Authors & Publishers
Publication Years
Category
Studies & Reports
6
COVID-19
3
Virology
3
Policies & Guidelines HIV & TB
2
Communicable Diseases
1
Hepatitis
1
Monitoring & Evaluation
1
NCD
1
Demograhic Health Surveys DHS
1
Policies
1
Guidelines
1
Drugs & Medical Equipment
1
Community Health
1
Capacity Building
1
Statistics
1
Respiratory Infections
1
Health Systems
1
Toolboxes
Diagnostics & Laboratory Guidance
15
Genomic sequencing
6
Surveillance & Contact tracing
5
HIV testing & services
4
Laboratory Guidance
3
Clinical Guidelines
3
Children & Adolescents
2
Public Health
2
Studies & Reports
2
Reports & Studies
2
Eastern and Southern Africa
2
Agriculture & Veterinary
1
Clinical Aspects
1
HIV testing & disclosure
1
Hepatitis
1
Global
1
Discrimination & Stigma
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Public Health
1
Training, others
1
Country specific documents
1
Common Good
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
Nurses
1
Planetary Health
1
Agriculture
1
Women
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Reports & Studies Children HIV
1
28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients.
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic...
